- Home
- APLT vs USEG Comparison
APLT vs USEG Comparison
Compare APLT & USEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- USEG
- Stock Information
- Founded
- APLT 2016
- USEG 1966
- Country
- APLT United States
- USEG United States
- Employees
- APLT N/A
- USEG N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- USEG Oil & Gas Production
- Sector
- APLT Health Care
- USEG Energy
- Exchange
- APLT Nasdaq
- USEG Nasdaq
- Market Cap
- APLT 80.3M
- USEG 68.6M
- IPO Year
- APLT 2019
- USEG N/A
- Fundamental
- Price
- APLT $0.52
- USEG $1.21
- Analyst Decision
- APLT Buy
- USEG Strong Buy
- Analyst Count
- APLT 7
- USEG 2
- Target Price
- APLT $6.10
- USEG $2.75
- AVG Volume (30 Days)
- APLT 1.6M
- USEG 336.8K
- Earning Date
- APLT 05-08-2025
- USEG 03-13-2025
- Dividend Yield
- APLT N/A
- USEG N/A
- EPS Growth
- APLT N/A
- USEG N/A
- EPS
- APLT N/A
- USEG N/A
- Revenue
- APLT N/A
- USEG $19,343,000.00
- Revenue This Year
- APLT N/A
- USEG $23.82
- Revenue Next Year
- APLT $2,426.33
- USEG N/A
- P/E Ratio
- APLT N/A
- USEG N/A
- Revenue Growth
- APLT N/A
- USEG N/A
- 52 Week Low
- APLT $0.43
- USEG $0.81
- 52 Week High
- APLT $10.62
- USEG $6.40
- Technical
- Relative Strength Index (RSI)
- APLT 43.47
- USEG 32.95
- Support Level
- APLT $0.52
- USEG $1.37
- Resistance Level
- APLT $0.62
- USEG $1.53
- Average True Range (ATR)
- APLT 0.05
- USEG 0.10
- MACD
- APLT 0.01
- USEG 0.01
- Stochastic Oscillator
- APLT 23.19
- USEG 5.88
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About USEG U.S. Energy Corp. (DE)
US Energy Corp is an independent energy company. It is focused on the acquisition and development of oil and natural gas-producing properties in the continental United States. It has business activities in South Texas and the Williston Basin in North Dakota. The company generates revenue from its interest in the sales of oil and natural gas production.